Cargando…
A stochastic model for immunotherapy of cancer
We propose an extension of a standard stochastic individual-based model in population dynamics which broadens the range of biological applications. Our primary motivation is modelling of immunotherapy of malignant tumours. In this context the different actors, T-cells, cytokines or cancer cells, are...
Autores principales: | Baar, Martina, Coquille, Loren, Mayer, Hannah, Hölzel, Michael, Rogava, Meri, Tüting, Thomas, Bovier, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827069/ https://www.ncbi.nlm.nih.gov/pubmed/27063839 http://dx.doi.org/10.1038/srep24169 |
Ejemplares similares
-
The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy
por: Ruotsalainen, Janne, et al.
Publicado: (2021) -
CXCR3: Here to stay to enhance cancer immunotherapy?
por: Rogava, Meri, et al.
Publicado: (2019) -
CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
por: Effern, Maike, et al.
Publicado: (2022) -
From Tpex to Tex: a journey through CD8(+) T cell responses in cancer immunotherapy
por: Messmer, Julia M., et al.
Publicado: (2023) -
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response
por: Ager, Casey R, et al.
Publicado: (2023)